Seattle immunology biotech signs $60M deal for its lupus drug

Alpine has the potential to receive an additional $805 million if the drug meets certain milestones.

Source: bizjournals.com Health Care:Biotechnology headlines - June 19, 2020 Category: Biotechnology Authors: Megan Campbell Source Type: news